胎盘门诊模式对胎儿生长受限的诊断与管理
该文阐述以母胎医学部为主的多学科胎盘门诊模式用于胎儿生长受限的诊断与管理。通过综合临床评估、胎儿超声、子宫动脉多普勒及胎盘形态学评估,并结合母血清胎盘生长因子等生物标志物提高诊断准确性。胎盘病理有助于评估复发风险并指导产后咨询与后续妊娠规划。
要点
- 胎盘门诊整合母胎医学、超声、遗传、新生儿、病理等多学科评估胎儿生长受限。
- 子宫动脉多普勒在早发型胎儿生长受限多数异常,并与子痫前期及母体血管灌注不良相关。
- 胎盘病理可评估复发风险,如大量绒毛周围纤维蛋白沉积等可复发。
核心结论
- 以母胎医学部为主的多学科胎盘门诊模式可用于胎儿生长受限的诊断与管理。
- 综合临床评估、胎儿超声、子宫动脉多普勒及胎盘形态学评估可提高诊断与预后判断。
研究设计与样本
- 本文为综述,阐述胎盘门诊模式对胎儿生长受限的诊断与管理。
主要发现
- 子宫动脉多普勒在早发型胎儿生长受限多数异常,并与子痫前期及母体血管灌注不良病理相关。
- 大量绒毛周围纤维蛋白沉积、慢性组织细胞性绒毛间隙炎或胎儿血栓性血管病可与正常子宫动脉多普勒波形相关。
- 胎盘超声在胎儿生长受限背景下可辅助诊断,如布鲁斯胎块(Breus\' mole)和三相倍体。
- 大量绒毛周围纤维蛋白沉积或慢性组织细胞性绒毛间隙炎在后续妊娠中复发率可>50%。
关键数值与推荐
- 母血清胎盘生长因子单独或联合可溶性fms样酪氨酸激酶-1可提高胎盘介导胎儿生长受限的诊断准确性。
- 胎盘形态学评估目前未纳入胎盘并发症筛查方案。
临床怎么用
- 胎盘门诊可提供产后咨询,针对可改变的母体危险因素进行有效指导。
- 胎盘病理可协助基于胎儿生长受限病理基础规划未来妊娠管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Effective detection and management of fetal growth restriction is relevant to all obstetric care providers. Models of best practice to care for these patients and their families continue to evolve. Since much of the disease burden in fetal growth restriction originates in the placenta, the concept of a multidisciplinary placenta clinic program, managed primarily within a maternal-fetal medicine division, has gained popularity. In this context, fetal growth restriction is merely one of many placenta-related disorders that can benefit from an interdisciplinary approach, incorporating expertise from specialist perinatal ultrasound and magnetic resonance imaging, reproductive genetics, neonatal pediatrics, internal medicine subspecialties, perinatal pathology, and nursing. The accurate diagnosis and prognosis for women with fetal growth restriction is established by comprehensive clinical review and detailed sonographic evaluation of the fetus, combined with uterine artery Doppler and morphologic assessment of the placenta. Diagnostic accuracy for placenta-mediated fetal growth restriction may be enhanced by quantification of maternal serum biomarkers including placenta growth factor alone or combined with soluble fms-like tyrosine kinase-1. Uterine artery Doppler is typically abnormal in most instances of early-onset fetal growth restriction and is associated with coexistent preeclampsia and underlying maternal vascular malperfusion pathology of the placenta. By contrast, rare but potentially more serious underlying placental diagnoses, such as massive perivillous fibrinoid deposition, chronic histiocytic intervillositis, or fetal thrombotic vasculopathy, may be associated with normal uterine artery Doppler waveforms. Despite minor variations in placental size, shape, and cord insertion, placental function remains, largely normal in the general population. Consequently, morphologic assessment of the placenta is not currently incorporated into current screening programs for placental complications. However, placental ultrasound can be diagnostic in the context of fetal growth restriction, for example in Breus' mole and triploidy, which in turn may enhance diagnosis and management. Several examples are illustrated in our figures and supplementary videos. Recent advances in the ability of multiparameter screening and intervention programs to reduce the risk of severe preeclampsia will likely increase efforts to deliver similar improvements for women at risk of fetal growth restriction. Placental pathology is important because the underlying pathologies associated with fetal growth restriction have a wide range of recurrence risks. Rare conditions such as massive perivillous fibrinoid deposition or chronic histolytic intervillositis may recur in >50% of subsequent pregnancies. Postpartum care in a placenta-focused program can provide effective counseling for modifiable maternal risk factors, and can assist in planning future pregnancy care based on the pathologic basis of fetal growth restriction.
引用
- Kingdom JC, Audette MC, Hobson SR, et al. A placenta clinic approach to the diagnosis and management of fetal growth restriction. Am J Obstet Gynecol. 2017. PMID: 29254754. doi:10.1016/j.ajog.2017.11.575
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。